Neumora Therapeutics, Inc. (NMRA)

Neumora Therapeutics, Inc. (NMRA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $89.4M; returns 1 day -6.5%, 1 week -19.9%, 1 year -83.6%.

Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutic treatments for a broad range of brain diseases, including neuropsychiatric disorders and neurodegenerative diseases.

Groups NMRA belongs to

• Clinical Stage Biotech
• Biotechnology
• Neuroscience
• Clinical Stage
• CNS Disorders
• Healthcare
• Pharmaceuticals
• Precision Medicine
• Neurological Disorders
• Alzheimer's Disease
• Mental Health Solutions

NMRA financial model: income statement, cash flow and balance sheet